European Leukemia Trial Registry
Trial: HD-Melphalan

More Details
Title High-dose melphalan and autologous SCT in relapsed AML
Scientific Title High-dose melphalan with autologous stem cell transplantation in patients with relapsed acute myeloid leukemia (AML)
Short Title HD-Melphalan
Trialgroup NN
Type of Trial multicentric
Disease Acute myeloid leukemia(AML) AML all subtypes without FAB M3
Age >= 18 years
Status No longer recruiting
Start of Recruitment 05.04.2004
Leader Martin, PD Dr. med., Hans
Contactperson

Study Physician
Bug, PD Dr. med., Gesine
Tel: +49 (0)69 6301 7369
Fax: +49 (0)69 6301 7463
Email: g.bug@em.uni-frankfurt.de

Centre of Trial Universitätsklinikum Frankfurt
Shortprotocol Shortprotocol
created 10.07.2006 Anja Hellenbrecht
changed 19.01.2015 Hanna Ebert
© ELIC European Leukemia Information Center | no responsibility is taken for correctness and completeness of this information | www.leukemia-net.org | elic@leukemia-net.org